MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-02-0003675
Trimurthi Pharmaceuticals (India) Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.91 Cr
▼ 16% YoY
Net profit · FY 2025
₹8.15 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹17.35 Lakh
EBITDA margin 4.4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹16.56 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
About Trimurthi Pharmaceuticals (India) Private Limited
Data last updated:
Trimurthi Pharmaceuticals (India) Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Trimurthi Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 April 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2012PTC080276. Its GSTIN is 36AARCS4380H2ZU (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It was formerly known as Skf Lifescience Private Limited. It is led by directors Arvind Kumar Bhangadia (Whole-Time Director) and Aditya Bhangadia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4 – 4 – 231/1/2/Abc Inderbagh Sultan Bazar, Hyderabad, Telangana, India – 500095.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.91 Cr, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹8.15 Lakh (net margin 2.1%) and EBITDA of ₹17.35 Lakh (EBITDA margin 4.4%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 6% over five years.
The company is associated with 1 brand: MediGin. As per MCA filings, the company has open charges of ₹16.56 Lakh on record.
Trimurthi Pharmaceuticals (India) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0003675). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medigin.in.
Company details
CIN U24232TG2012PTC080276
Registration Number 080276
Incorporation Date 12 April 2012
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Trimurthi Limited
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0003675
CIN history
Trimurthi Pharmaceuticals (India) has one previous CIN (Corporate Identification Number): U24232AP2012PTC080276. The current CIN is U24232TG2012PTC080276, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2012PTC080276 | Current |
| U24232AP2012PTC080276 | Previous |
Recognitions & Rankings of Trimurthi Pharmaceuticals (India)
Contact details
Trimurthi Pharmaceuticals (India) Private Limited's registered office is in Hyderabad, Telangana. Its website is medigin.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Apps
- Registered Address4 – 4 – 231/1/2/Abc Inderbagh Sultan Bazar, Hyderabad, Telangana, India – 500095
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Trimurthi Pharmaceuticals (India) Private Limited, buy the company report.
Comprehensive company report
Trimurthi Pharmaceuticals (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Trimurthi Pharmaceuticals (India) operates one associated brand: MediGin. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides a mobile app for convenient online purchase of medicines. | medigin.in |
Business activity
The main business activity of Trimurthi Pharmaceuticals (India) is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Trimurthi Pharmaceuticals (India) Private Limited, buy the company report.
Financials of Trimurthi Pharmaceuticals (India) Private Limited
FY 2025 filings availableTrimurthi Pharmaceuticals (India) Private Limited reported revenue of ₹3.91 Cr (down 16% YoY) for FY 2025.
Revenue · FY 2025
₹3.91 Cr ▼ 16%
Net profit · FY 2025
₹8.15 Lakh margin 2.1%
EBITDA · FY 2025
₹17.35 Lakh margin 4.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 20%
5 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 33%
5 years · compounded
▲ 13%
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 16% fall in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.35 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.4% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Trimurthi Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of Trimurthi Pharmaceuticals (India) Private Limited
Trimurthi Pharmaceuticals (India) has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Bhangadia | Director | 03 Sep 2016 | 10 Years 1 Months | Current |
| Arvind Kumar Bhangadia Also directs: Axcenor India LLP | Whole-Time Director | 01 Jun 2015 | 11 Years 4 Months | Current |
Auditor
Trimurthi Pharmaceuticals (India) Private Limited is audited by P. Murali & Co for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P. Murali & Co | FY 2022 | 007257S |
Shareholding
The shareholding of Trimurthi Pharmaceuticals (India) Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Trimurthi Pharmaceuticals (India) Private Limited, buy the company report.
Charges & borrowings
Open charges
₹16.56 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Apr 2022 | 100593093 | Hdfc Bank Limited | ₹16.56 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Trimurthi Pharmaceuticals (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trimurthi Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Trimurthi Pharmaceuticals (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AARCS4380H2ZU | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Trimurthi Pharmaceuticals (India) Private Limited, buy the company report.
Recent activity
Trimurthi Pharmaceuticals (India) Private Limited has 7 board changes on record since 2013: 2 appointments and 5 cessations. The latest: Aditya Bhangadia ceased to be Director on 01 Oct 2020.
AGM
Trimurthi Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Trimurthi Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 16.56 Lakh with Charge ID 100593093 was registered on 16 Apr 2022.
Ceased
Aditya Bhangadia ceased to be Director.
Ceased
Arvind Kumar Bhangadia ceased to be Director.
Appointed
Aditya Bhangadia was appointed as Director.
Ceased
Manish Sarda Govindrao ceased to be Director.
Appointed
Arvind Kumar Bhangadia was appointed as Whole-Time Director.
Ceased
Pramod Jagannath Bhagdiya ceased to be Director.
Ceased
Ravi Bhangadia ceased to be Director.
Incorporation
12 Apr 2012
Trimurthi Pharmaceuticals (India) Private Limited was registered on 12 Apr 2012 with Roc Hyderabad & aged 14 years 6 months as per MCA records.
Frequently asked questions
Trimurthi Pharmaceuticals (India) is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 April 2012 (14+ years old) and is registered under CIN U24232TG2012PTC080276.
Trimurthi Pharmaceuticals (India) has 2 current directors:
- Arvind Kumar Bhangadia - Whole-Time Director
- Aditya Bhangadia - Director
The latest financial statements of Trimurthi Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Trimurthi Pharmaceuticals (India) is 36AARCS4380H2ZU, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Trimurthi Pharmaceuticals (India) is U24232TG2012PTC080276. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trimurthi Pharmaceuticals (India) was incorporated on 12 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
Aditya Bhangadia ceased to be Director on 01 Oct 2020. Arvind Kumar Bhangadia ceased to be Director on 01 Oct 2020. Aditya Bhangadia was appointed as Director on 03 Sep 2016. Trimurthi Pharmaceuticals (India) has 7 board changes on record in total.
Yes, Trimurthi Pharmaceuticals (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0003675).
Trimurthi Pharmaceuticals (India) can be reached through the website medigin.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Trimurthi Pharmaceuticals (India) is at 4 – 4 – 23112Abc Inderbagh Sultan Bazar, Hyderabad, Telangana, India – 500095.